DaVita price target raised to $136 from $114 at Deutsche Bank Deutsche Bank raised its price target for DaVita to reflect its 2014 estimates and calls the company its top pick within Health Care Providers. The firm reiterates a Buy rating on the name.
News For DVA From The Last 14 Days
Check below for free stories on DVA the last two weeks.
Revised CMS ruling favorable for dialysis providers, says Wells Fargo Wells Fargo said the Centers for Medicare & Medicaid Services eliminated the impact of the rebase in its revised rules from for its proposed accountable care demonstration project for dialysis providers, which is a positive for the providers. The firm keeps an Outperform rating on DaVita HealthCare (DVA) and a Market Perform rating on Fresenius Medical (FMS).